This ICL will cover the most recent updates regarding the uses of orthobiologics when managing of orthopaedic patients. Discussion topics will include regulatory aspects of orthobiologics; basic science and clinical evidence in the treatment of osteoarthritis and soft tissue restoration; and strategies for billing in the use of orthobiologics.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Non-member | $80 |
| Member | $40 |
| Free Activity | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- No reviews yet. Be the first to share yours.
Faculty 3
All faculty
- Enduring / On-demand
- Credit · Up to 3 credits
- MOC · Up to 3 points
- $40 member · $80 standard
-
ReleasedJun 12, 2024
-
Last day to claim creditJun 12, 2027 8 months left
-
Arthroscopy Association of North America Orthopaedic Use of Biologics in 2025 (AANA25)
-
Arthroscopy Association of North America Joint Preservation Techniques for the Knee in 2024: The Utility of Biologics, Osteotomies and Cartilage Restoration Procedures (2024 Annual Meeting)
-
Arthroscopy Association of North America Cartilage Conundrums in 2024: Cases From the Experts (2024 Annual Meeting)
-
American Orthopaedic Society for Sports Medicine IC 304-2024: How to Incorporate Orthobiologics in your Practice: Safe, Effective, and Ethical
-
American Academy of Orthopaedic Surgeons Annual Meeting 2025 on Demand: Orthobiologics for shoulder and sports injuries: What is the evidence?
-
Med Learning Group Enhancing the Management of Osteoarthritis: Insights on Defining Early-Stage Disease and Intra-Articular Interventions
